Aligning Administration Workforce given New Refined Industrial Concentrate on Establishments Beginning with Latest Appointment of Board Member Zhenya Lindgardt as Interim President and CEO
Engages Main Technique Home to Consider Finest Pathways Towards Focusing on Enhanced Income Technology at Considerably Lowered Working Prices
Nadia Altomare Anticipated to Transfer from Chief Industrial Officer to Consulting Position to Assist Driving Effectivity and Effectiveness in Our Industrial Spend in Partnership with Our Exterior and Inside Workforce
SALT LAKE CITY, Might 25, 2023 /PRNewswire/ — Sera Prognostics Inc., The Being pregnant Firm® (NASDAQ: SERA), centered on enhancing maternal and neonatal well being by offering progressive being pregnant biomarker info to medical doctors and sufferers, in the present day introduced sure industrial adjustments and plans to optimize its technique and industrial construction to extremely focus enterprise actions on accelerating check adoption and income at considerably decreased working prices.
These plans embrace adjustments to raised align management with a brand new refined industrial deal with establishments and cost-effectively accelerating check adoption and income prematurely of upcoming knowledge readouts. This course of began with the latest appointment of Board Member Zhenya Lindgardt, a seasoned enterprise operator for high-growth organizations, as interim President and CEO, introduced on Might 15, 2023.
Sera Prognostics has additionally engaged a number one technique home to carefully consider one of the best pathways towards enhanced income at considerably decreased value to extra broadly commercialize the corporate’s PreTRM® Take a look at and pipeline of expertise. This analysis is anticipated to be inclusive of environment friendly market focus and potential strategic partnerships. As a part of this course of, Nadia Altomare is anticipated to maneuver from Chief Industrial Officer to a consulting function to help driving effectivity and effectiveness in our industrial spend in partnership with our exterior and inner group.
The Firm has additionally made choose headcount reductions at month finish in its industrial group to raised map present industrial and advertising and marketing prices towards refined deal with these alternatives being deemed as probably the most profitable within the near-term from a check adoption and income era perspective. Sera Prognostics is evaluating different methods to additional optimize its enterprise whereas decreasing working prices and defending its sturdy stability sheet, which at present affords a powerful basis towards realization of the Firm’s targets outlined in the present day coupled with concentrating on improved shareholder valuation.
“We’re taking decisive and well-defined steps to optimize for market success given the macro setting, whereas additionally making an allowance for the rising function we search to play in establishing our first-of-its-kind PreTRM check as an ordinary of care in defending moms and infants,” mentioned Sera Prognostics interim CEO, Zhenya Lindgardt. “Whereas change is at occasions difficult, we anticipate our actions will show profitable in supporting our objective to be The Being pregnant Firm whereas fostering important development, and we’re grateful for our group’s function in making a paradigm shift in being pregnant care to create higher healthcare outcomes for expectant moms and their kids.”
About Sera Prognostics, Inc.
Sera Prognostics is a number one well being diagnostics firm devoted to enhancing the lives of girls and infants by means of precision being pregnant care. Sera’s mission is to offer early, pivotal being pregnant info to enhance the well being of moms and newborns, leading to reductions within the prices of healthcare supply. Sera has a strong pipeline of progressive diagnostic exams centered on the early prediction of preterm start threat and different problems of being pregnant. Sera’s precision medication PreTRM® Take a look at stories to a doctor the individualized threat of spontaneous untimely supply in a being pregnant, enabling earlier proactive interventions in ladies with larger threat. Sera Prognostics is situated in Salt Lake Metropolis, Utah.
About Preterm Delivery
Preterm start is outlined as any start earlier than 37 weeks’ gestation and is the main explanation for sickness and dying in newborns. The 2022 March of Dimes Report Card exhibits that, for the final 4 consecutive years, multiple in ten infants is born prematurely. Prematurity is related to a considerably elevated threat of main long-term medical problems, together with studying disabilities, cerebral palsy, power respiratory sickness, mental incapacity, seizures, and imaginative and prescient and listening to loss, and may generate important prices all through the lives of affected kids. The annual well being care prices to handle short- and long-term problems of prematurity in the US have been estimated to be roughly $25 billion for 2016.
Concerning the PreTRM® Take a look at
The PreTRM® Take a look at is the one broadly validated, commercially obtainable blood-based biomarker check that gives an early, correct and individualized threat prediction for spontaneous preterm start in asymptomatic singleton pregnancies. The PreTRM® Take a look at measures and analyzes proteins within the blood which are extremely predictive of preterm start. The PreTRM® Take a look at permits physicians to determine, in the course of the weeks 18 by means of 20 of being pregnant, which ladies are at elevated threat for preterm start and its problems, enabling extra knowledgeable, customized medical choices based mostly on every girl’s particular person threat. The PreTRM® Take a look at is ordered by a medical skilled.
Sera Prognostics, the Sera Prognostics brand, The Being pregnant Firm, and PreTRM are logos or registered logos of Sera Prognostics, Inc. in the US and/or different international locations.
Protected Harbor Assertion
This press launch comprises “forward-looking statements” inside the which means of the Personal Securities Litigation Reform Act of 1995, together with statements referring to accelerating check adoption and income; concentrating on enhanced income era at considerably decreased working prices; driving effectivity and effectiveness in our industrial spend; upcoming knowledge readouts; potential strategic partnerships; additional optimizing the Firm’s enterprise; improved shareholder valuation; establishing the Firm’s first-of-its-kind PreTRM check as an ordinary of care; fostering important development; and the corporate’s strategic directives below the caption “About Sera Prognostics, Inc.” These “forward-looking statements” are based mostly on administration’s present expectations of future occasions and are topic to quite a lot of dangers and uncertainties that might trigger precise outcomes to vary materially and adversely from these set forth in or implied by forward-looking statements. These dangers and uncertainties embrace, however will not be restricted to: internet losses, money era, and the potential want to boost extra capital; revenues from the PreTRM Take a look at representing considerably all Firm revenues up to now; the necessity for broad scientific and market acceptance of the PreTRM Take a look at; a concentrated variety of materials prospects; our potential to introduce new merchandise; potential competitors; our proprietary biobank; crucial suppliers; the COVID-19 pandemic and its potential lingering influence on our operations, in addition to the enterprise or operations of third events with whom we conduct enterprise; estimates of complete addressable market alternative and forecasts of market development; potential third-party payer protection and reimbursement; new reimbursement methodologies relevant to the PreTRM Take a look at, together with new CPT codes and cost charges for these codes; adjustments in FDA regulation of laboratory-developed exams; the mental property rights defending our exams and market place; and different components mentioned below the heading “Danger Elements” contained in our Remaining Prospectus on Kind S-1, which was filed with the Securities and Alternate Fee on July 14, 2021, in addition to any updates to these threat components filed sometimes in our Quarterly Experiences on Kind 10-Q, Annual Experiences on Kind 10-Okay, or Present Experiences on Kind 8-Okay. All info on this press launch is as of the date of the discharge, and the Firm undertakes no responsibility to replace this info until required by regulation.
SOURCE Sera Prognostics, Inc.
